A pharmaceutical manufacturing model that does not own its own factories, instead using contract manufacturers while handling raw material supply, technology provision, manufacturing management, and quality assurance in-house. It has subsequently expanded into comprehensive CRDMO collaborations covering everything from mRNA design through manufacturing, evaluation, formulation, nonclinical studies, and IND consulting.